The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 ...
Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety between teenagers and adults in an NIH study.
With the clade 1 outbreak of mpox (formerly monkeypox) raging through the Congo and other countries in Central Africa, ...
The world “cannot be complacent” about the threat posed by mpox, Anneliese Dodds has warned, as the UK unveiled up to £9 ...
An independent study has found that Bavarian Nordic's mpox vaccine Jynneos – currently only authorised for use in adults in ...
A clinical trial by the US National Institutes of Health (NIH) has shown that Bavarian Nordic’s mpox vaccine induced an antibody response in adolescents equivalent to that of adults. The interim ...
WHO has approved Bavarian Nordic's mpox vaccine for adolescents, expanding access as global concern over the viral outbreak ...
Children, adolescents and those with weakened immune systems have been particularly vulnerable to mpoxThe World Health ...
Africanews English on MSN5d
Bavarian Nordic mpox vaccine gets green light from WHO for use in adolescentsAfter approving Bavarian Nordic’s mpox vaccine in September for use in adults, the World Health Organisation has given the vaccine the green light for use in adolescents aged 12 to 17 years. It comes ...
The World Health Organization (WHO) on Monday announced that it has it had approved Bavarian Nordic’s mpox vaccine for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback